Sumitomo Chemical India (SUMICHEM) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
18 Jan, 2026Executive summary
Revenue for Q2 FY25 rose 9% year-over-year to INR 988 crore, and H1 FY25 revenue increased 12% to INR 1,827 crore, driven by volume growth, new product launches, and normalization of export markets.
PAT for Q2 FY25 increased 34% to INR 193 crore; H1 PAT up 56% to INR 319 crore, supported by improved margins and cost management.
EBITDA for Q2 FY25 grew 31% year-over-year to INR 245 crore, with margin at 24.8%; H1 EBITDA margin rose to 22.2% from 16.5% YoY.
Focused on profitability, strategic pricing, and disciplined financial management amid challenging weather and market conditions.
Launched successful farmer engagement campaigns and new products, contributing to robust demand generation.
Financial highlights
Q2 FY25 revenue: INR 988 crore (+9% YoY, +18% QoQ); H1 FY25 revenue: INR 1,827 crore (+12% YoY).
Q2 gross margin: 42.6% (+421 bps YoY, +365 bps QoQ); Q2 EBITDA: INR 245 crore (+31% YoY, +52% QoQ); EBITDA margin: 24.8% (+402 bps YoY).
Q2 PAT: INR 193 crore (+34% YoY, +52% QoQ); PAT margin: 19.5% (+360 bps YoY).
H1 EBITDA: INR 402-406 crore (+51% YoY); H1 EBITDA margin: 22.2% (vs. 16.5% YoY).
H1 PAT: INR 319 crore (+56% YoY); H1 net profit margin: 17.5% (vs. 12.6% YoY).
Outlook and guidance
Management expects robust demand in H2, supported by high water reservoir levels and favorable soil moisture.
Full-year domestic value growth guidance revised to 9-10%, with volume growth expected to remain strong.
Margins expected to remain in the 18-20% EBITDA range for FY25, with potential for upside if current trends persist.
Ongoing investments in R&D, capacity expansion, and digital marketing to drive future growth.
No further significant price declines anticipated in H2; price impact already absorbed in H1.
Latest events from Sumitomo Chemical India
- 9MFY26 revenue rose 5% with margin gains, but Q3 saw profit drop from one-time Labour Code charge.SUMICHEM
Q3 25/2630 Jan 2026 - Double-digit growth, record margins, and strong outlook, amid regulatory and climate risks.SUMICHEM
Q4 24/257 Jan 2026 - H1 FY26 delivered 9% revenue growth, robust cash flow, and new launches despite Q2 headwinds.SUMICHEM
Q2 25/2628 Oct 2025 - Record Q1FY26 revenue and profit growth, with strong margins and ongoing regulatory risks.SUMICHEM
Q1 25/265 Sep 2025 - Q1FY25 saw strong revenue and profit growth, improved margins, and ongoing legal and seasonal risks.SUMICHEM
Q1 24/255 Sep 2025 - Q3FY25 saw robust revenue and profit growth, led by exports, with ongoing seasonal and regulatory risks.SUMICHEM
Q3 24/255 Sep 2025